Vaccine Pipeline Review - Oct 2008
VacZine Analytics
October 1, 2008 57 Pages - SKU: VZAN1917350
|
|
Vaccine Pipeline Review (October 2008) is a comprehensive database which allows effective monitoring of the fasting moving vaccine R&D pipeline. The database contains around 365 validated entries of active commercial vaccine programs covering over 80 companies. It can be used for competitive intelligence, business development and strategic planning activities. In the database, each program comes with predicted BLA and MAA filing dates along with key details such as clinical trial information, partner details, vaccine composition e.g. adjuvants and predicted market segment(s). The database also comes with a key findings presentation showing relevant database outputs in graph form and key changes since the last publication and opportunity assessments. The database is updated every 4-6 months.
Please note: this is delivered as a Zip file.
|
- Current vaccine pipeline
- R&D programs by phase/market
- R&D programs (Top five companies)
- R&D programs by company
- Corporate changes
- Discontinued/suspended projects
- Key changes: paediatric vaccines
- Key predicted filings: paediatric vaccines
- Human Papillomavirus (HPV)
- Key changes: meningitis
- Key changes: Streptococcus pneumoniae
- Key predicted filings: Streptococcus pneumoniae
- Key changes: Novel
- Key predicted filings: Novel
- Key changes: Travel/Endemic
- Key predicted filings: Travel/Endemic
- Key changes: Influenza (Seasonal)
- Key predicted filings: Influenza (Seasonal)
- Key changes: Influenza (Pandemic)
- Adjuvants (clinical and launched products)
- Year-on-year new product approvals to 2015
- Opportunity Heatmap
- Methodology
Share this report
Other tasks Related Markets Vaccines Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
